More News

21 Mar 2019 Alexion and Affibody Announce Partnership to Co-Develop Anti-FcRn Affibody® Molecule
20 Mar 2019 Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics
20 Mar 2019 Domainex and SpiroChem Enter a Fragment Drug Discovery Partnership
20 Mar 2019 Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases
19 Mar 2019 Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD
19 Mar 2019 Ono Pharmaceutical and twoXAR Announce Drug Discovery Research Collaboration
14 Mar 2019 Merck KGaA, Darmstadt, Germany, Announces Collaboration With Iktos for Generative Artificial Intelligence (AI) Technology
13 Mar 2019 Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca
13 Mar 2019 Flow Pharma, Inc. and OncoImmunity AS partner for the Development of FlowVaxTM Personalized Cancer Vaccines
13 Mar 2019 HitGen and SPARC Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration
11 Mar 2019 Parkinson’s disease: Servier and Oncodesign join forces to investigate new line of research
11 Mar 2019 Stemline In-Licenses Worldwide Rights to Novel Selective RET Inhibitor (SL-1001); Expands Oncology Pipeline
11 Mar 2019 Principia Biopharma Reacquires Rights to Oral Immunoproteasome Program
11 Mar 2019 aTyr Pharma Announces Research Collaboration With Global Biotherapeutics Leader CSL Behring
11 Mar 2019 Bridge Medicines Enters Agreement with Weill Cornell Medicine to Develop a Novel Sphingosine 1-Phosphate (S1P) Receptor Modulator
09 Mar 2019 TaiwanJ Pharmaceuticals Obtained US$26M Deal for Licensing and Co-Development Contract with Newsoara Biopharma on JKB-122 Asian Rights
09 Mar 2019 Xencor Announces Closing of Research Collaboration and License Agreement with Genentech
06 Mar 2019 ReForm Biologics Announces Collaboration Agreement with Astellas Pharma Inc.
06 Mar 2019 AnTolRx Announces Pfizer Exercises Option To License Immune Tolerance Therapy For Potential Treatment Of Type 1 Diabetes
06 Mar 2019 Glenmark Pharmaceuticals Announces Appointment of Alessandro Riva as CEO of its New Innovation Company
06 Mar 2019 Iksuda Therapeutics and Femtogenix sign license agreement
05 Mar 2019 Numab Announces Entry into a License Agreement With Intarcia for Anti-Inflammatory ND016
05 Mar 2019 Xenetic Biosciences, Inc. Announces Agreement to Acquire Innovative CAR T Technology Platform
04 Mar 2019 Adagene Announces a Platform Evaluation of the Dynamic Precision Library with Celgene Corporation
04 Mar 2019 NantKwest Signs Worldwide License Agreement with ProMab Biotechnologies to Exclusively Develop Select Next Generation Targeted Natural Killer Cell Therapeutics

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up